CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients

BACKGROUND: Early detection of capecitabine-resistance could largely increase overall survival of colorectal cancer (CRC) patients. Previous studies suggested examination of immune cells in peripheral blood would help to predict efficacy of chemotherapy. METHODS: We examined the immunological charac...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yu, Huang, Yizhou, Huang, Lei, Xu, Yanjie, Wang, Zien, Li, Han, Zhang, Ting, Zhong, Ming, Gao, Wei-qiang, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414545/
https://www.ncbi.nlm.nih.gov/pubmed/32770940
http://dx.doi.org/10.1186/s12865-020-00375-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414545/
https://www.ncbi.nlm.nih.gov/pubmed/32770940
http://dx.doi.org/10.1186/s12865-020-00375-8

Ejemplares similares